MD-PhD Program 36th Annual Retreat
Friday, September 28 - Sunday, September 30, 2018
Red Jacket Resort
South Yarmouth, Cape Cod
The annual fall retreat, organized by the program students and staff, is the most important collegial activity of the academic year. First held in 1983, this retreat takes place at a local New England conference center. This year it will be held on Cape Cod. All MD-PhD students are included, whether or not they have MSTP funding. HMS sponsors the retreat, with financial assistance from industry donors. Faculty members active on program committees are also invited. Typically, more than half of the students and 25-30 faculty members attend, with most faculty presenting posters. The retreat is highly interactive. The program varies from year to year, but usually includes oral presentations and posters by students about their thesis research, and discussions about postgraduate training and career choices. In addition, a prominent physician-scientist is invited to give a keynote lecture, named for Eva Neer, M.D., a strong faculty supporter of the program who died of breast cancer in 2000.
This year the Eva Neer Memorial Lecture will be delivered by George Q. Daley, M.D., Ph.D.
George Q. Daley, MD, PhD
"Blood from a Petri Dish"
George Q. Daley, M.D., Ph.D., is the Dean of Harvard Medical School. A world-renowned physician-scientist and educator, his achievements span basic science, translational research and clinical medicine.
Daley is at the forefront of stem cell science and cancer biology, and his
discoveries have twice been cited in Science’s Top 10 Breakthroughs of the Year.
His research paved the way for Gleevec, a “magic bullet” drug for chronic myeloid leukemia; generated stem cell models for more than a dozen human diseases; and advanced our understanding of tissue regeneration and bone marrow transplantation therapies. He has also been a central force in establishing international guidelines for the conduct of stem cell research.
Daley earned his A.B. and M.D. degrees from Harvard and Ph.D. in
biology from MIT, and has worked as a trainee, fellow and staff physician at several HMS-affiliated hospitals.
Through their differentiation in vitro, pluripotent stem cells can be employed for the study of embryonic hematopoietic development, and hold promise for modeling genetic diseases of the blood like immune deficiency, bone marrow failure, and hemoglobinopathy. While current protocols for directing hematopoietic differentiation faithfully recapitulate myeloid lineages, and there have been encouraging reports of NK, B and T cell development, recapitulating the various stages of hematopoietic ontogeny and producing bona fide hematopoietic stem cells (HSC) has proven elusive. Novel strategies to achieve the production of specific hematopoietic lineages, and to achieve the ultimate goal of HSC derivation will be discussed, alongside illustrations of the utility of ESC/iPSC in disease
Click to view past retreat group photos:
2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1989 | 1986 | 1983
November 15, 2018